Author:
Dinan Laurence,Dioh Waly,Veillet Stanislas,Lafont Rene
Abstract
There is growing interest in the pharmaceutical and medical applications of 20-hydroxyecdysone (20E), a polyhydroxylated steroid which naturally occurs in low but very significant amounts in invertebrates, where it has hormonal roles, and in certain plant species, where it is believed to contribute to the deterrence of invertebrate predators. Studies in vivo and in vitro have revealed beneficial effects in mammals: anabolic, hypolipidemic, anti-diabetic, anti-inflammatory, hepatoprotective, etc. The possible mode of action in mammals has been determined recently, with the main mechanism involving the activation of the Mas1 receptor, a key component of the renin–angiotensin system, which would explain many of the pleiotropic effects observed in the different animal models. Processes have been developed to produce large amounts of pharmaceutical grade 20E, and regulatory preclinical studies have assessed its lack of toxicity. The effects of 20E have been evaluated in early stage clinical trials in healthy volunteers and in patients for the treatment of neuromuscular, cardio-metabolic or respiratory diseases. The prospects and limitations of developing 20E as a drug are discussed, including the requirement for a better evaluation of its safety and pharmacological profile and for developing a production process compliant with pharmaceutical standards.
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference182 articles.
1. Ecdysone: From Chemistry of Mode of Action,1989
2. On the distribution of phytoecdysteroids in plants
3. Phytoecdysteroids: Diversity, biosynthesis and distribution;Dinan,2009
4. The Ecdysone Handbook
http://ecdybase.org/
5. Dietary Phytoecdysteroids;Dinan,2020
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献